Inhibition of Pim-2 kinase by LT-171-861 promotes DNA damage and exhibits enhanced lethal effects with PARP inhibitor in multiple myeloma.

Biochemical Pharmacology
Cen ZhaoNa Lu

Abstract

Multiple myeloma (MM) is a malignancy of antibody-producing plasma cells with genomic instability and genetic abnormality as its two hallmarks. Therefore, DNA damage is pervasive in MM cells, which indicates irregular DNA damage response (DDR) pathway. In this study, we demonstrated that LT-171-861, a multiple kinase inhibitor, could inhibit proliferation and induce apoptosis in MM cells. LT-171-861 promoted DDR pathway and triggered DNA damage through impeding the process of homologous recombination in double strand breaks, rather than directly elevating ROS level in MM cells. Mechanism research revealed that Pim2 inhibition was responsible for LT-171-861-indcued DNA damage and cell apoptosis. LT-171-861 mainly suppressed Pim2 kinase activity and reduced the expression of its phosphorylated substrates, such as 4EBP1 and BAD. Moreover, Olaparib, a PARP inhibitor, could enhance the antitumor effect of LT-171-861 in suppressing tumor growth in MM xenografted nude mice. Taken together, our results demonstrated that LT-171-861 showed a promising therapeutic potential for MM and had an additional lethal effect with PARP inhibitors.

References

Sep 5, 2003·The Journal of Biological Chemistry·Bin YanMichael Lilly
Jul 21, 2004·The Prostate·Alexander ValdmanLars Egevad
Jul 11, 2008·Nature·Libor MacůrekRené H Medema
Dec 30, 2014·Lancet·Christoph RölligMartin Bornhäuser
Nov 19, 2015·BioMed Research International·Antonia CagnettaMichele Cea
Apr 2, 2016·Nature Reviews. Molecular Cell Biology·Per HydbringPiotr Sicinski
Aug 27, 2016·Blood Cancer Journal·J RamachandranN Raje
Jan 28, 2017·Nature Reviews. Cancer·Tobias Otto, Piotr Sicinski
Jun 6, 2017·Frontiers in Oncology·Ana Belén Herrero, Norma Carmen Gutiérrez
Jun 9, 2018·Drug Design, Development and Therapy·Domenica LorussoFrancesco Raspagliesi
Feb 23, 2020·Haematologica·Daniele CaraccioloPierfrancesco Tassone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis